Get startedLog in
    Picture of Zhong Yuan Bio-Technology Holdings logo

    ZHYBF — Zhong Yuan Bio-Technology Holdings Income Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro Cap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Zhong Yuan Bio-Technology Holdings, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

    2020
    March 31st
    C2021
    March 31st
    R2022
    March 31st
    R2023
    March 31st
    2024
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:20-F20-F20-F20-F20-F
    Standards:
    USG
    USG
    USG
    USG
    USG
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue1.221.642.331.662.28
    Cost of Revenue
    Gross Profit0.9631.351.911.522.07
    Selling / General / Administrative Expenses
    Research And Development
    Unusual Expense / Income
    Total Operating Expenses1.311.653.013.362.01
    Operating Profit-0.086-0.015-0.686-1.70.267
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes-0.087-0.028-0.672-1.680.271
    Provision for Income Taxes
    Net Income After Taxes-0.087-0.028-0.683-1.670.272
    Minority Interest
    Net Income Before Extraordinary Items
    Extraordinary Items
    Net Income-0.087-0.028-1.13-2.150.302
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income-0.087-0.028-1.13-2.150.302
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS-0.005-0.002-0.04-0.0880.017